Nail Outcome Improvements with Certolizumab Pegol in Moderate to Severe Plaque Psoriasis: Results from Phase 3 Trials

Main Article Content

A.B. Gottlieb
D Thaci
C Leonardi
Y Poulin
S Kavanagh
M Boehnlein
K Reich

Keywords

psoriasis, certolizumab, nail

Abstract

Abstract not available.

References

1. Certolizumab Pegol Prescribing Information. Available at http://
www.accessdata.fda.gov.

2. Certolizumab Pegol Summary of Product Characteristics. Available at http://www.ema.europa.eu/ema.

3. Gottlieb AB. et al. JAAD. 2018;79:302–14.e6.

4. Lebwohl M. et al. JAAD. 2018;79:266–76.e5.

5. van der Heijde D. RMD Open. 2018;4:e000582.